(Q33503301)

English

Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). (English)

1 reference

Europe PubMed Central

27 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Cascinu S

1

1 reference

Europe PubMed Central

27 July 2017

Labianca R

2

1 reference

Europe PubMed Central

27 July 2017

Graziano F

3

1 reference

Europe PubMed Central

27 July 2017

Pancera G

4

1 reference

Europe PubMed Central

27 July 2017

Barni S

5

1 reference

Europe PubMed Central

27 July 2017

Frontini L

6

1 reference

Europe PubMed Central

27 July 2017

Luporini G

7

1 reference

Europe PubMed Central

27 July 2017

Cellerino R

8

1 reference

Europe PubMed Central

27 July 2017

Catalano G

9

1 reference

Europe PubMed Central

27 July 2017

language of work or name

0 references

publication date

1 August 1998

1 reference

Europe PubMed Central

27 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

27 July 2017

78

1 reference

Europe PubMed Central

27 July 2017

3

1 reference

Europe PubMed Central

27 July 2017

390-393

1 reference

Europe PubMed Central

27 July 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1998.505

0 references

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063041

21 June 2018

Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063041

21 June 2018

Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063041

21 June 2018

Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063041

21 June 2018

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063041

21 June 2018

Gastric adenocarcinoma: CT versus surgical staging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063041

21 June 2018

New developments in the treatment of gastric carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063041

21 June 2018

Endoscopic Ultrasonography in the Diagnosis, Staging and Follow-Up of Esophageal and Gastric Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063041

21 June 2018

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063041

21 June 2018

Adjuvant and neoadjuvant therapy for gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063041

31 October 2018

Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction

1 reference

https://pubmed.ncbi.nlm.nih.gov/9703289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimates of the worldwide frequency of sixteen major cancers in 1980

1 reference

https://pubmed.ncbi.nlm.nih.gov/9703289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9703289

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1998.505

1 reference

Europe PubMed Central

27 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33503301&oldid=1584672837"